Weight-Loss Medication Cost in Bangkok 2026 (GLP-1)

GLP-1 Weight-Loss Medication Cost in Bangkok

If you are a man researching what weight-loss injections actually cost in Bangkok, here is the short version before the detail.

• Monthly medication cost: roughly THB 8,000-19,000 per month for a GLP-1 injection, depending on the drug (Ozempic, Wegovy or Mounjaro), the dose, and whether you go to a specialist men's clinic or a premium private hospital.

• Program extras: an initial consultation, a body-composition (InBody) scan, and baseline bloodwork add roughly THB 4,000-12,000 across a typical 3-6 month program.

• Versus the West: Bangkok pricing can be up to ~50-70% lower than US list and insurance-gap pricing (~USD 1,000+/month) - though new US direct cash-pay programs have narrowed the gap (see comparison below).

• The catch: these are prescription-only medicines that legally require an in-person medical evaluation in Thailand. They are not suitable for everyone and carry real contraindications.

GLP-1 in plain English: GLP-1 ("glucagon-like peptide-1") medicines are weekly or daily injections that mimic a natural gut hormone. They slow stomach emptying and reduce appetite signals in the brain, so you feel full sooner and eat less. They do not "burn fat" directly - the weight loss comes from eating less, which makes preserving muscle a priority (more on that below).

This article is educational and does not replace a medical consultation. GLP-1 medication in Thailand requires a prescription and an in-person assessment. The figures below are indicative 2026 ranges based on publicly advertised Bangkok pricing; confirm exact costs and your own suitability at a consultation.

---

What These Medications Are (and Why Men Use Them)

The medicines driving Bangkok's weight-loss market belong to two families:

• GLP-1 receptor agonists - semaglutide (sold as Ozempic for diabetes and Wegovy for weight management) and liraglutide (Saxenda, a daily injection).

• Dual GLP-1/GIP receptor agonists - tirzepatide (sold as Mounjaro, and as Zepbound for weight management), which acts on two gut-hormone pathways and is currently the most effective option in head-to-head data.

For men specifically, the appeal is usually a stubborn pattern that diet and gym alone have not shifted: central, visceral fat around the abdomen that drives waist size, blood-pressure creep, and worsening blood-sugar control. GLP-1 medicines reduce appetite and overall calorie intake, which is why they work where willpower-based dieting has plateaued. They are a medical tool, not a shortcut - the best results come when the medication is paired with resistance training and adequate protein to protect muscle.

If your weight gain sits alongside low energy, low libido or other symptoms, the underlying picture may be hormonal as well as metabolic. That is a separate evaluation - see our guides on TRT vs peptide therapy and testosterone support. Testosterone is not a weight-loss drug for men with normal levels, and bundling it into a fat-loss plan without a clinical reason is a red flag.

---

Bangkok Weight-Loss Medication Prices (2026): Full THB Table

The single biggest question for this topic is cost, so here it is upfront. Prices below are per one-month supply at Bangkok private clinics and hospitals in 2026, expressed in Thai baht (THB) and approximate US dollars. Ranges reflect the spread between mid-tier specialist clinics and premium private hospitals (which can run 1.4-2x higher for the same dose).

*Indicative 2026 ranges; confirm at consultation. Hospital pricing (e.g. major Bangkok private hospitals) tends to sit at the top of - or above - these ranges for the same drug and dose.*

A few things men commonly misread:

• Price scales with dose. You typically start low and step up (see titration below), so your first months may cost less than your maintenance months.

• A "pen" is not always a month. Weekly pens (Ozempic, Wegovy, Mounjaro) usually cover about four weeks. Saxenda is a daily injection: at the 3.0mg maintenance dose a single pen lasts only about six days, so a month needs roughly five pens - which is why daily dosing makes its monthly cost relatively high for the weight loss delivered.

• Compounded "generic semaglutide" is cheaper for a reason. Unlicensed compounded versions are not authorised for sale in Thailand unless made by a Thai-FDA-approved compounding pharmacy, and quality is not guaranteed. See the safe-clinic section.

Consultation, scan and bloodwork costs

The medication is only part of the program. A legitimate plan includes evaluation and monitoring:

InBody scan, in plain English: a 60-second standing body-composition test that estimates how much of your weight is fat versus muscle and water. It matters here because GLP-1 weight loss includes some muscle, so tracking lean mass - not just the scale - is part of doing this safely.

What a typical program actually costs

To answer the real question - "what will this cost me, all in?" - here is a worked example for a 3-month starter program at a mid-tier Bangkok specialist clinic, using a weekly GLP-1:

• Medication: ~THB 9,000-15,000/month × 3 ≈ THB 27,000-45,000

• Initial consult + InBody + baseline bloodwork: ≈ THB 2,500-5,000

• 2-3 follow-up consults: ≈ THB 1,000-2,400

• Indicative 3-month total: ~THB 30,000-52,000 (roughly USD 850-1,500)

Always ask the clinic exactly what is included: does the quoted price cover follow-up consults, the InBody scan, dose increases during titration, and repeat bloodwork - or are those add-ons? What's included varies widely between providers.

---

Thailand vs the West: The Savings Story

The reason Bangkok ranks for this query is value. The same branded medicines have long cost dramatically less here than at their Western list prices, largely because of pricing and reimbursement differences rather than any difference in the drug itself.

*Western figures are indicative list/self-pay ranges and vary widely with insurance, pharmacy and discount programs. The US column reflects list and insurance-gap pricing; new direct cash-pay programs are lower (see below). UK Mounjaro reflects the higher private-supply range after Eli Lilly's September 2025 list-price increase.*

The headline used to be simple: Bangkok was commonly 50-70% cheaper than US self-pay pricing. That still holds against US list and insurance-gap pricing, which can run USD 1,000+ per month. But the picture changed in late 2025: after the US "most-favoured-nation" pricing deal, manufacturers rolled out direct cash-pay programs - Wegovy at roughly USD 349/month (all doses) and Zepbound (tirzepatide) vials at roughly USD 299-449/month via the manufacturer's direct channel. Against those current US cash prices, Bangkok (~USD 230-560) is comparable or only modestly cheaper, not 50-70% cheaper.

So the savings case depends on the channel you would otherwise use:

• Versus US list/insurance-gap pricing (USD 1,000+): Bangkok is dramatically cheaper - the ~50-70% saving holds.

• Versus the newest US direct cash-pay programs (Wegovy ~USD 349, Zepbound vials ~USD 299-449): the gap is small, and for some doses Bangkok is roughly on par.

• Versus the UK: the gap narrows further, because NHS/private UK supply can be competitive - so the strongest savings case is for patients who would otherwise pay US list prices, or who are Gulf-based.

Note: weight-loss medication is generally not covered by Thai or international health insurance, so most patients pay out of pocket; ask your clinic about installment options.

---

Who Qualifies - and Who Should NOT Take GLP-1s

These are not lifestyle supplements. Clinical eligibility matters, and so do contraindications.

Eligibility (who is typically a candidate)

International guidance generally supports GLP-1 weight-management treatment for adults with:

• BMI ≥ 30 (obesity), or

• BMI ≥ 27 with at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea).

Because Asian populations carry more visceral fat and metabolic risk at a lower BMI, lower thresholds are often applied in this region - commonly BMI ≥ 27.5 for obesity, or ≥ 23-25 with a comorbidity. This is one reason a local, in-person assessment matters: a Bangkok-based clinician will calibrate to your build and risk profile rather than a Western default.

Who should NOT take GLP-1 medication (contraindications)

Boxed warning - read this. These medicines (semaglutide products, liraglutide/Saxenda and tirzepatide) carry a regulatory boxed warning (the strongest warning a medicine can carry) against use in anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). This is based on thyroid tumours seen in rodent studies; the human risk is unproven, but the contraindication stands.

Do not start, or use only with specialist guidance, if you have:

• A personal or family history of medullary thyroid cancer or MEN2 (absolute contraindication).

• A history of pancreatitis (inflammation of the pancreas).

• A history of gallbladder disease or gallstones.

• Type 1 diabetes or diabetic ketoacidosis (these drugs are not a substitute for insulin).

• Severe gastrointestinal disease such as gastroparesis.

• Pregnancy, planned pregnancy, or breastfeeding (relevant if your partner is a candidate; for men, this is rarely the limiting factor but is part of the full label).

A proper consultation screens for all of the above. A clinic that prescribes without taking this history is cutting corners.

---

How It Works: Dosing, Titration and Timeline

GLP-1 medicines are started low and increased slowly - a process called titration - to limit nausea and other gut side effects. A typical weekly semaglutide ramp looks like this:

1. Weeks 1-4: 0.25 mg weekly (a starting "tolerance" dose, not yet a full treatment dose).

2. Weeks 5-8: 0.5 mg weekly.

3. Weeks 9-12: 1.0 mg weekly.

4. Beyond: step up further toward a maintenance dose as tolerated and as your clinician directs.

Tirzepatide (Mounjaro) follows its own stepwise schedule from a low starting dose upward. Appetite usually drops within the first few weeks; visible weight change typically becomes clear over 2-3 months, with the largest losses accumulating across 6-12 months of continued treatment.

The patient journey is consistent at any reputable clinic: consultation and history → baseline bloodwork and InBody scan → first prescription at the starting dose → follow-up every 2-4 weeks to adjust the dose and check tolerance → ongoing monitoring of weight, muscle and blood markers.

---

What Results to Expect (Real Numbers)

This is where men should calibrate expectations against evidence, not marketing.

• Semaglutide 2.4 mg (Wegovy): in the STEP 1 trial, adults with obesity lost on average about 14.9% of body weight over 68 weeks.

• Tirzepatide (Mounjaro): in the head-to-head SURMOUNT-5 trial, tirzepatide produced about 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks - roughly 22.8 kg vs 15.0 kg.

• Waist circumference: in the same trial, waist fell by about −18.4 cm with tirzepatide vs −13.0 cm with semaglutide - directly relevant to the visceral, belly-first fat pattern many men carry.

Two important caveats, both especially relevant to a male, gym-aware audience:

• Muscle matters. A meaningful share of GLP-1 weight loss is lean mass - in STEP 1, roughly 45% of total weight lost came from lean mass. Resistance training and adequate protein during treatment are not optional extras; they protect your strength and metabolic rate.

• Stopping usually means regaining. In the STEP 1 extension, participants regained about two-thirds of their lost weight within a year of stopping semaglutide, despite continued lifestyle guidance - and the regained weight is largely fat. Durable results usually require either ongoing medication or a sustained, structured lifestyle program.

---

Side Effects and Risks

Most side effects are gastrointestinal and tend to ease as your body adjusts and as the dose is titrated slowly.

Common (usually mild, often temporary):

• Nausea

• Vomiting

• Diarrhoea or constipation

• Reduced appetite, early fullness, mild reflux

• Fatigue, especially early on

Less common but more serious - seek medical care:

• Severe, persistent abdominal pain (possible pancreatitis - stop and get assessed urgently).

• Right upper-abdomen pain, fever or jaundice (possible gallbladder problems).

• Signs of dehydration from prolonged vomiting or diarrhoea.

• Severe allergic reaction.

Red-flag rule: sustained, severe abdominal pain is the symptom to never ignore on a GLP-1. Stop the medication and seek urgent care. Long-term safety data continues to mature; ongoing medical supervision is part of responsible use, not an optional upgrade.

---

Drug-vs-Drug Comparison

For most men starting out, a weekly semaglutide is the common entry point; tirzepatide is escalated to when greater loss is the goal and budget allows. Your clinician should make this call based on your targets, tolerance and medical history - not on what is on promotion.

---

Where to Buy Safely in Bangkok (and Counterfeit Red Flags)

GLP-1 demand has produced a grey market. The price-versus-safety trade-off is real, and choosing the wrong source is the single biggest risk in this whole category.

Your options, roughly:

• Licensed private hospital - highest trust, highest price (often the THB 14,000-17,000+ end), full medical oversight.

• Licensed specialist clinic (including men's-health clinics) - strong oversight at mid-tier pricing, with treatment tailored to you.

• Retail pharmacies - variable; only Thai-FDA-approved pharmacies may legally dispense, and only against a valid prescription.

• Online "no prescription" sellers and compounded copies - cheapest and most dangerous; avoid.

Avoid any provider that:

• Sells unregulated or compounded GLP-1 "copies" not approved by the Thai FDA.

• Will prescribe online only, with no in-person evaluation and no medical history.

• Performs no bloodwork before starting.

• Does not monitor your progress with scheduled follow-ups.

• Pushes extreme calorie restriction alongside the drug, or bundles in testosterone without a clinical reason.

• Cannot tell you the source and licensing of the medication, or sells pens with damaged or non-original packaging.

Choose a provider that verifies licensing, requires baseline blood tests, sources medication from licensed pharmaceutical suppliers, schedules follow-ups every 2-4 weeks, and - for men - evaluates the metabolic and hormonal picture together rather than handing over a pen.

---

A Note on Prescription and Legality in Thailand

Semaglutide and tirzepatide are prescription-only in Thailand. They are not legitimate over-the-counter purchases, and a proper, legal pathway requires an in-person medical evaluation and a prescription from a licensed doctor. Compounded semaglutide may not be sold unless produced by a Thai-FDA-approved compounding pharmacy, and importing compounded versions privately is illegal. If you are a tourist or expat planning to continue treatment, ask your clinic for proper prescription documentation - and note that travellers are generally limited to carrying about 30 days' supply in original packaging.

---

Talk to Menscape

Menscape is a men's-health clinic in Bangkok offering medically supervised, prescription-based weight-management programs built around male physiology - visceral-fat reduction, muscle preservation, and where relevant, the metabolic-hormonal link. Programs include a proper consultation, baseline bloodwork, body-composition tracking, and scheduled follow-ups, using medication sourced from licensed suppliers.

If you want to understand whether GLP-1 treatment is appropriate for you - and what your realistic, all-in cost would be - book a private consultation. A clinician will assess your eligibility, screen for contraindications, and build a plan around your goals.

*This guide is for general education and is not medical advice. GLP-1 weight-loss medication requires a prescription and an in-person medical consultation.*

Frequently Asked Questions

How much does weight-loss medication actually cost per month in Bangkok?

For a one-month supply of a GLP-1 injection, expect roughly THB 8,000-19,000 depending on the drug and dose: Ozempic around THB 8,000-13,000, Wegovy around THB 10,000-19,000, and Mounjaro around THB 11,000-17,000 or more. Daily Saxenda runs around THB 10,000-15,000 a month (about five pens). Premium private hospitals sit at the top of - or above - these ranges. Add roughly THB 4,000-12,000 across a program for the consultation, an InBody scan, and bloodwork. All figures are indicative 2026 ranges; confirm at consultation.

Is it cheaper to get Ozempic or Mounjaro in Bangkok than in the US?

It depends which US price you compare against. Versus US list and insurance-gap pricing (often USD 1,000+ per month), Bangkok can be up to ~50-70% cheaper. But new US direct cash-pay programs introduced in late 2025 - Wegovy around USD 349/month and Zepbound (tirzepatide) vials around USD 299-449/month - have narrowed the gap, so against those Bangkok (~USD 230-560) is comparable or only modestly cheaper. The savings case is strongest for patients who would otherwise pay US list prices, or who are Gulf-based; against the UK the gap is smaller. Weight-loss medication is generally not covered by insurance, so most people pay out of pocket either way.

Which is more effective, semaglutide or tirzepatide?

In the head-to-head SURMOUNT-5 trial, tirzepatide (Mounjaro) produced about 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks - roughly 22.8 kg versus 15.0 kg, with a greater waist-circumference reduction too. Tirzepatide is currently the most effective option in trial data, though semaglutide is often the starting point and the right choice depends on your goals, tolerance and budget.

Will I regain the weight if I stop the medication?

Most likely yes, at least in part. In the STEP 1 trial extension, participants regained about two-thirds of their lost weight within a year of stopping semaglutide, despite continued lifestyle guidance, and the regained weight was largely fat. Durable results usually require either ongoing medication or a sustained, structured lifestyle program. This is why these are best viewed as long-term metabolic treatments, not short courses.

Who should not take GLP-1 weight-loss medication?

These medicines (semaglutide, liraglutide/Saxenda and tirzepatide) carry a boxed warning against use in anyone with a personal or family history of medullary thyroid cancer (MTC) or MEN2 syndrome. They are also generally avoided in people with a history of pancreatitis or gallbladder disease, type 1 diabetes or diabetic ketoacidosis, severe gastrointestinal disease, and in pregnancy or breastfeeding. A proper consultation screens for all of these before prescribing.

What are the common side effects?

Most are gastrointestinal: nausea, vomiting, diarrhoea or constipation, reduced appetite and mild reflux, plus some early fatigue. These usually ease as the dose is titrated up slowly. Rare but serious problems include pancreatitis (severe, persistent abdominal pain) and gallbladder issues - if you have severe ongoing abdominal pain, stop the medication and seek urgent care.

Do GLP-1 medications cause muscle loss?

A meaningful share of the weight lost on GLP-1s is lean mass - in the STEP 1 trial, roughly 45% of total weight lost came from lean mass. This matters for men, because losing muscle reduces strength and metabolic rate. Resistance training and adequate protein during treatment help protect muscle, which is why a good program tracks body composition (with an InBody scan), not just the number on the scale.

Do I need a prescription to buy weight-loss injections in Thailand?

Yes. Semaglutide and tirzepatide are prescription-only in Thailand and legally require an in-person medical evaluation. Only Thai-FDA-approved pharmacies may dispense them, and only against a valid prescription. Compounded or unlicensed copies are not authorised for sale unless made by a Thai-FDA-approved compounding pharmacy, and privately importing compounded versions is illegal. Avoid any 'no prescription' or online-only seller.

Is testosterone a weight-loss treatment for men?

No. Testosterone (TRT) is not a weight-loss drug for men with normal levels, and bundling it into a fat-loss plan without a clinical reason is a red flag. That said, if weight gain comes with low energy or low libido, the underlying picture may be partly hormonal, which is a separate evaluation. A men's-health clinic can assess the metabolic and hormonal picture together rather than treating weight in isolation.

How quickly will I see results?

Appetite usually drops within the first few weeks. Visible weight change typically becomes clear over 2-3 months, with the largest losses accumulating across 6-12 months of continued treatment. Because the dose is increased gradually (titration) to limit side effects, your early weeks are about tolerance-building rather than maximum effect.

References

• Wilding JPH et al. Weight regain after withdrawal of semaglutide: STEP 1 trial extension. Diabetes, Obesity and Metabolism (2022)

• Aronne LJ et al. SURMOUNT-5: Tirzepatide vs Semaglutide for weight loss (American College of Cardiology summary)

• Cleveland Clinic: GLP-1 Agonists - mechanism, side effects and risks

• Bumrungrad International Hospital: Injectable weight-loss medications (semaglutide vs tirzepatide, Asian-population BMI eligibility)

• U.S. FDA boxed warning context: GLP-1 receptor agonists and medullary thyroid carcinoma / MEN2

• Lancet Diabetes & Endocrinology: GLP-1 receptor agonist eligibility and BMI thresholds across populations00356-0/fulltext)

• Konkai Health: Ozempic in Thailand - costs and hospitals (Bangkok THB pricing reference)

• Circulation (AHA): Muscle mass and GLP-1 receptor agonists - lean-mass loss during weight reduction